Keel Point’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,499
| Closed | -$303K | – | 531 |
|
|
2026
Q1 | $303K | Sell |
3,499
-2,151
| -38% | -$206K | 0.02% | 351 |
|
|
2025
Q4 | $543K | Buy |
5,650
+521
| +10% | +$50.6K | 0.03% | 279 |
|
|
2025
Q3 | $489K | Sell |
5,129
-176
| -3% | -$16.2K | 0.03% | 305 |
|
|
2025
Q2 | $462K | Buy |
5,305
+1,354
| +34% | +$115K | 0.03% | 314 |
|
|
2025
Q1 | $355K | Buy |
3,951
+1,385
| +54% | +$124K | 0.03% | 319 |
|
|
2024
Q4 | $205K | Buy |
+2,566
| New | +$222K | 0.02% | 413 |
|
|
2023
Q4 | – | Sell |
-3,735
| Closed | -$293K | – | 358 |
|
|
2023
Q3 | $293K | Sell |
3,735
-574
| -13% | -$48.1K | 0.04% | 242 |
|
|
2023
Q2 | $380K | Buy |
4,309
+369
| +9% | +$31.8K | 0.05% | 204 |
|
|
2023
Q1 | $318K | Buy |
3,940
+251
| +7% | +$20.5K | 0.05% | 214 |
|
|
2022
Q4 | $287K | Sell |
3,689
-1,075
| -23% | -$87.1K | 0.05% | 221 |
|
|
2022
Q3 | $385K | Sell |
4,764
-27
| -0.6% | -$2.43K | 0.07% | 165 |
|
|
2022
Q2 | $451K | Buy |
4,791
+217
| +5% | +$22K | 0.07% | 155 |
|
|
2022
Q1 | $507K | Sell |
4,574
-32,442
| -88% | -$3.43M | 0.08% | 148 |
|
|
2021
Q4 | $3.83M | Buy |
37,016
+5,384
| +17% | +$623K | 0.43% | 50 |
|
|
2021
Q3 | $3.96M | Buy |
31,632
+2,878
| +10% | +$373K | 0.51% | 38 |
|
|
2021
Q2 | $3.57M | Buy |
28,754
+2,923
| +11% | +$367K | 0.4% | 50 |
|
|
2021
Q1 | $3.05M | Buy |
25,831
+2,907
| +13% | +$341K | 0.3% | 54 |
|
|
2020
Q4 | $2.69M | Buy |
22,924
+3,133
| +16% | +$345K | 0.24% | 76 |
|
|
2020
Q3 | $2.06M | Buy |
19,791
+4,319
| +28% | +$434K | 0.19% | 79 |
|
|
2020
Q2 | $1.42M | Buy |
15,472
+709
| +5% | +$68K | 0.15% | 80 |
|
|
2020
Q1 | $1.33M | Buy |
14,763
+415
| +3% | +$44.2K | 0.17% | 59 |
|
|
2019
Q4 | $1.63M | Buy |
14,348
+2,186
| +18% | +$240K | 0.18% | 57 |
|
|
2019
Q3 | $1.32M | Sell |
12,162
-430
| -3% | -$44.9K | 0.16% | 62 |
|
|
2019
Q2 | $1.23M | Buy |
12,592
+2,341
| +23% | +$214K | 0.14% | 66 |
|
|
2019
Q1 | $934K | Buy |
10,251
+2,598
| +34% | +$233K | 0.11% | 77 |
|
|
2018
Q4 | $696K | Buy |
7,653
+4,259
| +125% | +$398K | 0.09% | 89 |
|
|
2018
Q3 | $334K | Buy |
3,394
+558
| +20% | +$51.6K | 0.04% | 136 |
|
|
2018
Q2 | $243K | Buy |
+2,836
| New | +$237K | 0.03% | 146 |
|
Other funds holding MDT
Keel Point's MDT Position: Q2 2026 in Review
Keel Point sold out of Medtronic (MDT) in Q2 2026, closing a stake of 3,499 shares — an estimated $303K sold.
Keel Point first reported a position in MDT in Q2 2018 and held it in 28 quarters. The position peaked at $3.96M in Q3 2021. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Keel Point reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
- Keel Point sold 3,499 Medtronic shares in Q2 2026, an estimated $303K.
- Keel Point first reported a position in Medtronic in Q2 2018 and held it in 28 quarters.
- Keel Point's Medtronic position peaked at $3.96M in Q3 2021.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Keel Point's 13F filing for Q2 2026, filed 14 Aug 2026.